Related Experiment Video
Updated: Mar 6, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions
Yuan Shen1,2, Shanshan Liu1,3, Jiao Fan1,4
1Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, China.
Abstract:
The protein p53 plays a crucial role in the regulation of cellular responses to diverse stresses. Thus, a major priority in cell biology is to define the mechanisms that regulate p53 activity in response to stresses or maintain it at basal levels under normal conditions. Moreover, further investigation is required to establish whether RNA participates in regulating p53's interaction with other proteins. Here, by conducting systematic experiments, we discovered a p53 interactor-hnRNPC-that directly binds to p53, destabilizes it, and prevents its activation under normal conditions. Upon doxorubicin treatment, the lncRNA SNHG1 is retained in the nucleus through its binding with nucleolin and it competes with p53 for hnRNPC binding, which upregulates p53 levels and promotes p53-dependent apoptosis by impairing hnRNPC regulation of p53 activity. Our results indicate that a balance between lncRNA SNHG1 and hnRNPC regulates p53 activity and p53-dependent apoptosis upon doxorubicin treatment, and further indicate that a change in lncRNA subcellular localization under specific circumstances is biologically significant.
Insights
The protein hnRNPC normally suppresses p53 activity. However, the lncRNA SNHG1 binding to hnRNPC upon doxorubicin treatment releases p53, promoting apoptosis.
Area of Science:
- Cell Biology
- Molecular Biology
- RNA Biology
Background:
- The tumor suppressor protein p53 regulates cellular stress responses.
- Understanding p53 regulation mechanisms is crucial for cell biology.
- The role of RNA in modulating protein interactions, including p53, requires further investigation.
Purpose of the Study:
- To identify novel interactors of p53.
- To elucidate the regulatory mechanisms of p53 activity by RNA.
- To investigate the role of hnRNPC and SNHG1 in p53 regulation and apoptosis.
Main Methods:
- Systematic experimental screening for p53 interactors.
- Biochemical assays to determine direct binding and effects on protein stability.
- Analysis of RNA-protein interactions and subcellular localization.
- Assessment of p53-dependent apoptosis upon doxorubicin treatment.
Main Results:
- hnRNPC directly binds to p53, destabilizing it and inhibiting its activation under normal conditions.
- Doxorubicin treatment causes lncRNA SNHG1 to bind nucleolin, retaining it in the nucleus.
- SNHG1 competes with p53 for hnRNPC binding, leading to p53 upregulation and apoptosis.
- A balance between SNHG1 and hnRNPC regulates p53 activity and apoptosis.
Conclusions:
- hnRNPC acts as a negative regulator of p53 under normal conditions.
- lncRNA SNHG1 modulates p53 activity by sequestering hnRNPC upon doxorubicin treatment.
- The subcellular localization and interaction dynamics of lncRNA SNHG1 are critical for p53-mediated apoptosis.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
lncRNA - Long Non-coding RNAs
Regulation of Nuclear Protein Sorting
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
The Nucleolus

